简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

TBC医疗集团宣布2000万美元股票回购计划

2025-12-31 21:35

  • SBC Medical Group (SBC) announced on Wednesday a share repurchase program and the filing of a Form S-3 registration statement with the U.S. Securities and Exchange Commission (SEC). 
  • The company’s board of directors has authorized a $20 million share repurchase program, pursuant to which the company may repurchase shares of its common stock from time to time through open market transactions, through privately negotiated transactions, or by other means, in accordance with applicable securities laws and restrictions. The repurchase program terminates on December 31, 2026, and may be modified, suspended or discontinued at any time in the Company’s discretion.
  • The company’s Form S-3 Registration Statement, which was declared effective by the SEC on December 30, 2025, enables the company to offer and sell, from time to time in one or more offerings, up to $50 million of common stock or preferred stock on a primary basis.
  • The company said it is not selling any securities from the shelf registration statement at this time, and if the company decides to raise capital in a future offering using the shelf registration statement, the Company will describe the specific details of that future offering in a prospectus supplement that is filed with the SEC. The firm added that it believes that a shelf registration on Form S-3 will provide greater flexibility to raise capital in the future, to facilitate growth, including domestic and international M&A, and supports its efforts to increase its public float.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2026 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号